Atrion Corp (ATRI) - Multiplikator forward rega marang pendapatan
The forward P/S based on forecasts demonstrates stable demand for Atrion Corporation (ATRI) cardiology and infusion products, where the value of 4.40 characterizes this level. Atrion Corporation (ATRI) is creating an ecosystem of high-precision components integrated into the OEM projects of B2B partners. Business resilience is supported by the control of polymer supplies and clinic demand for anesthesiology tubes while maintaining a healthy operating margin.
Atrion - rincian analitis lan metrik utama (ATRI)
- rega pasar lan target rega analis:
- indikator kapitalisasi pasar:
- rincian valuasi buku bisnis:
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Atrion Corporation|ATRI - Rasio utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Atrion Corporation|ATRI - Tanggungan utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Atrion Corp|ATRI - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Atrion|Indikator likuiditas cepet atrioncorp.com
- data bathi bisnis lan rasio investasi:
ATRI - Bathi sawise mbayar pajeg|Bathi sing dikarepake Atrion Corporation|ATRI - Nilai perusahaan marang bathi resik|Pangali Forward P/E atrioncorp.com|ATRI - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Atrion Corporation Inc.|ATRI - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Atrion|ATRI - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan atrioncorp.com|ATRI - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Atrion Corporation
- data dodolan lan asil:
Analisis umum perusahaan:ATRI (Atrion Corporation Inc.)
For Atrion Corporation (ATRI), whose long-term contracts in the medical systems niche guarantee a stable cash flow, the forward P/S based on forecasts reflects the market value of one dollar of expected revenue. This chart demonstrates a balance between the premium for high customer stickiness and the risks of overpaying for future growth, confirming the fundamental resilience of the business during periods of macroeconomic factor revaluation.
Analisis perusahaan pesaing
Rasio rega marang prakiraan pendapatan Intuitive Surgical Inc ISRG|Multiplikator Forward P/S Danaher Corporation Inc. DHR|BDX - Rasio rega marang prakiraan pendapatan|STERIS plc (STE) - Multiplikator forward rega marang pendapatan|WST: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Baxter International Inc. (BAX)|MASI (masimo.com) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Stevanato Group Corp STVN|Multiplikator forward rega marang pendapatan TFX (Teleflex Inc)|Merit Medical - Kapitalisasi marang prakiraan pendapatan|Envista Holdings - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake ICUI (ICU Medical Inc)|XRAY - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake LeMaitre Corp LMAT|ATRC: Multiplikator Forward P/S|STAA - Rasio kapitalisasi marang dodolan sing dikarepake|NAGE (Chromadex Corp) - Multiplikator Forward P/S|ZimVie Inc (ZIMV) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S ANGO|CERS (Cerus Corporation) - Rega forward marang dodolan|Multiplikator Forward P/S TKNO (Alpha Teknova, Inc.)|Monogram Technologies (MGRM) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|STSS - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake InfuSystem INFU|Utah Med (UTMD) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan KORU Medical Systems, Inc.|Multiplikator forward rega marang pendapatan NYXH|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Microbot Medical MBOT|Multiplikator forward rega marang pendapatan PDEX (Pro-Dex)|Rasio rega marang prakiraan pendapatan ZTEK (Zentek Limited)|Rasio rega marang prakiraan pendapatan Elutia Inc. ELUT|Milestone Scientific (MLSS) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|nexgel.com - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Retractable Technologies Inc.|Harvard Bioscience Inc. (HBIO) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Femasys Corp|Multiplikator forward rega marang pendapatan MHUA|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep predictive-oncology.com POAI|Rasio rega marang prakiraan pendapatan Callan JMB Corp (CJMB)|Rasio kapitalisasi marang dodolan sing dikarepake neurometrix.com
